At the low end, the drugs include $119,000 a year to treat certain rare genetic disorders. At the high end: a gene therapy ...

Thermo Fisher shows signs of post-COVID recovery, but modest growth, valuation risks, and macro pressures warrant caution.

A 492-strong Cardiff-based pharmaceutical firm has posted a fall in turnover and profits in its latest year amid a decrease ...

Evidence-based medicine "Boy Wonder" Dr. Vinay Prasad was fired as CBER Director after less than three months on the job.

Madbouly affirmed the government’s interest in providing all necessary support for the growth and localisation of this vital industry ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...

Trump on Thursday signed an executive order that set new tariffs on a wide swath of U.S. trading partners to go into effect ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

On the surface, the president appears to be working on lowering the costs of medications. Just below the surface, his efforts ...

President Donald Trump surprised pharma CEOs on Thursday with letters demanding they acquiesce to his most-favored ...

U.S. President Donald Trump’s new tariff rates of up to 41% on U.S. imports from dozens of countries drew expressions of ...